Lincoln Pharmaceuticals vs Peers
- Market cap
- ₹1,127 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹405.18 – ₹759.71
Lincoln Pharmaceuticals ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Lincoln Pharmaceuticals. Its P/E of 22.5 compares with a peer median of 22.5.
Lincoln Pharmaceuticals vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Lincoln Pharmaceuticals | 562.75 | -0.20% | 1,127 | 22.5 | 2.85 | 14.5% | +18.5% |
| Lincoln Pharmaceuticals | 562.75 | -0.20% | 1,127 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Lincoln Pharmaceuticals peer comparison — frequently asked questions
Who are Lincoln Pharmaceuticals' competitors?
Lincoln Pharmaceuticals' listed peers in Drug Manufacturers - Specialty & Generic include Lincoln Pharmaceuticals, ranked here by market capitalisation.
How does Lincoln Pharmaceuticals' P/E compare with its peers?
Lincoln Pharmaceuticals trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Lincoln Pharmaceuticals' peers?
By market capitalisation, the largest company in the group is Lincoln Pharmaceuticals at ₹1,127 crore, against ₹1,127 crore for Lincoln Pharmaceuticals.
Same Data For Peers
Trade Lincoln Pharmaceuticals With ATS
Track LINCOLN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.